Development of the ACGME Milestones 2.0 - November 28

The ACGME made a commitment from the outset all Milestones would be reviewed in the first four to five years to assess the need for revisions, edits and updating. The lessons learned (presented in Webinar 2) have provided rich data to move forward with a full-scale review and revision process for all Milestones sets between 2018 and 2021. The Milestones team refers to this initiative as Milestones 2.0. A number of specialties have already begun work on Milestones 2.0, including the inclusion of the UME voice in the process. 

Dr. Laura Edgar will share the new Milestone development and revision process and provide an update on progress and lessons learned to date.

Laura Edgar, EdD, CAE
Vice President, Milestones Development

Dr. Edgar is the Vice President for Milestone Development. She previously served as the Executive Director for Milestones Development and the Review Committees for Medical Genetics and Genomics, Pathology, and Radiation Oncology. In her current role, she leads volunteers and staff members through the development of Milestones and related materials. She has been influential in the development of Milestones for more than one hundred specialties. Dr. Edgar is a frequent speaker on topics related to the Milestones, Clinical Competency Committees, assessment, education, and accreditation.

Prior to joining the ACGME, Dr. Edgar worked in a clinical laboratory for 10 years, and then moved on to direct certification, education, and accreditation programs for various domestic and international medical and scientific organizations. Dr. Edgar earned her doctorate in organizational leadership after obtaining a baccalaureate degree in medical laboratory sciences and a master’s in business administration. She is a certified medical technologist and a certified association executive.

Components visible upon registration.